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Abstract—In this paper, a versatile, re-programmable,
current-input bioinstrumentation board is presented for electro-
chemical amperometric measurements. The proposed instrument
has been fabricated on a six layer printed circuit board (PCB)
and exploits dual switched-capacitor (SC) integration and sample-
and-hold (SH) techniques. It comprises off-the-shelf switch and
amplifier ICs and a commercially available FPGA-based DSP
unit for digital signal control and synchronisation. It features
eight amperometric channels, has a dynamic current range of
100dB, can be powered-up by a USB port or a 5V battery
and is portable, with dimensions of 110×110 mm2. An on-
board digital-to-analog converter (DAC) combined with standard
three-electrode potentiostats can provide precise, programmable
biasing voltages to eight amperometric biosensors simultaneously.
Validation of the robustness and accuracy of the proposed system
is demonstrated by proof-of-concept amperometric measurements
using a high-precision Keithley 6221 current source and NaCl
solution on a PCB-based sensor.
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I. INTRODUCTION
The need for diagnostic systems that can identify biomark-
ers at very low concentrations, e.g. pg/mL, is constantly
rising, as prognostic and diagnostic biodetection systems are
becoming more sensitive and more specific for various types of
diseases. Driven by modern advances in biochemistry, the con-
cept of a point-of-care (PoC) laboratory remains an interesting
and challenging aspect of clinical diagnosis. The benefits of
PoC laboratories are multidimensional, especially now that the
sustained expansion of the Internet of Things allows for rapid
diagnosis and efficient transmission of biological data from
anywhere [1]. A significant number of approaches to a large
variety of disease diagnostics have been attempted at PoC,
exploiting different techniques and materials. The lab-on-a-
PCB (LoPCB) approach is an alternative electrochemical de-
tection method, using amperometric sensors and microfluidics
produced by standard PCB manufacturing processes [2]–[4].
Inspired by the LoPCB framework for electrochemical
detection, the concept of a handheld, electronic Enzyme-
Linked Immuno-Sorbent Assay (“eELISA”) has been demon-
strated as the next step in future diagnostic technology [5].
The “eELISA” uses passive PCB-based sensors, where the
molecular reaction takes place, combined with high-precision,
multi-channel, portable bioinstrumentation platforms. In the
previous “eELISA” work, the bioinstrumentation platform has
been designed based on a low-noise transimpedance amplifier
(TIA) front-end combined with high-resolution voltage-input
analog-to-digital converters (ADCs). However, it should be
stressed that for small current levels (between few tenths of
pA up to few nA), traditional TIA setups require a high-value
feedback resistor (typically hundreds of MΩs up to several
GΩs) for adequate signal detection. Such feedback resistor
values usually compromise the signal’s integrity due to the
effect of thermal noise that they generate. Moreover, the high
cost and large area of high value resistors are not always
compatible with portable, low-cost PoC diagnostic platforms.
Herein, we introduce a novel paradigm for the “eELISA”
detection method, exploiting the idea of dual SC integration for
continuous current measurement [6], [7]. With the use of low-
cost, small-size SMD capacitors combined with inexpensive
switch ICs, fully reconfigurable SC-based topologies have been
designed, providing high dynamic current detection range.
Taking into consideration the need for continuous biosignal
measurement, this endeavour exploits the dual SC integration
technique, ensuring continuous current flow from the PCB-
based sensor, without interrupting its biasing. The instrument
features eight amperometric channels, each comprised of two
identical branches and four distinct stages: (a) dual SC in-
tegration, (b) SH, (c) amplification and finally (d) filtering.
Section II demonstrates the proposed architecture of the bioin-
strumentation platform and Section III presents experimental
data conducted with a high-precision Keithley 6221 current
source and NaCl solution on a PCB-based sensor. Section IV
discusses future prospects for the presented detection method.
II. BOARD’S ARCHITECTURE AND IMPLEMENTATION
A. Circuit Analysis
For ultra-low noise, high-precision current measurements,
the SC paradigm is preferable to a conventional TIA topology,
mainly due to the absence of the ohmic resistor and the sig-
nificant levels of thermal noise that TIAs introduce once high-
value transimpedance resistors are employed. In the SC case,
current is moving by charging and discharging appropriate
value capacitors, sunchronised by appropriate clock pulses that
open or close various switches of the SC topology [8], [9].
In Figure 1, a simplified schematic diagram of a single
channel based on the proposed architecture for continuous
amperometric measurements is presented. There are four dis-
tinct stages in each channel. The first stage includes the
dual SC integrators (integrators A and B). Two identical
branches, controlled by non-overlapping clocks F1 and F2
ensure constant current flow, as in every clock cycle the current
is switched from one branch to the other. As illustrated in
Figure 1, integrators A and B are operating in a complementary
manner. Focusing only on the upper integrator, integrator A,























































Fig. 1. A simplified schematic diagram of the fabricated bioinstrumentation board exploiting the dual SC integration technique for continuous current
measurement. Inset (I) is demonstrating the sampling and amplification stages of integrator A (integrator B operates in a complimentary manner). Inset (II)
shows the timing between the FPGA control signals.
A logic high of the F1 pulse is closing the upper front
switch. At the same time a logic zero is applied to the lower
front switch through pulse F2, opening the circuit. In that
case, current will travel through the upper branch and charge
capacitor CA. During this phase, the capacitor CA of integrator
B will discharge in a complementary manner. This phase
is called the sampling phase of integrator A, since CA is
sampling the input current. It is worth mentioning that the right
hand side of CA capacitor is always grounded. The voltage
that is developed across CA during this phase, because the







i(t)∂t, where t1 − t0 = 1/2f (1)
where f is sampling frequency. Similarly, when a logic low
of F1 pulse opens the upper front switch, at the same time
a logic high is applied to the lower front switch through
pulse F2, closing the circuit and steering the current towards
integrator B. During this phase, capacitor CA of integrator A
is discharging and capacitor CF is charging. The charge that
was stored in capacitor CA is now “transferred” to capacitor
CF . The capacitance of CF has been selected to be lower
compared to CA. Since it is charged with the same charge
as C1, higher amplified voltage will appear on its terminals.
For this reason, this phase is called amplification phase. By
changing the capacitance ratio, different amplifications could
be achieved and the output voltage can be calculated using
equation (2). At this phase, the capacitor CA of integrator B
is charging and CF is discharging in a complimentary manner.
Vout = (CA/CF )× VCA (2)
The circuit topology of both integrators is called non-inverting
SC amplifier, since Vout has the same polarity as Vin and the
gain is greater than unity, if CA > CF [8], [9]. For each
channel, three different capacitor values for CA and CF have
been placed, resulting into three fixed gain ranges (×2). As will
be shown later, this setup provides a wide dynamic current
range of detection, starting from a few nA to hundreds of
µA. At the end of integrators A and B, a dual SH circuit
has been placed (stage 2), whose switches are controlled by
the SH1 and SH2 pulses of the FPGA. The SH capacitors
store the output charge stemming from the two independent
integrators, applying a constant SC output voltage at the
input of a unity-gain amplifier. Stages 3 and 4 consist of re-
configurable amplification and filtering circuits, respectively.
Stage 3 provides three amplification factors (×1, ×2, ×5)
for non-inverting amplification. Finally, stage 4 consists of a
2nd-order Sallen-Key low pass filter, whose cut-off frequency
ranges from 1 to 500Hz, removing unwanted switching noise.
B. Fabricated Platform
A 6-layer PCB has been fabricated for testing the circuit
architecture shown in Section II-A. The board features 8 dual
integration SC amplifier channels and a 5V single-supply
operation. A photo of the fabricated system can be found
in Figure 2. The low-voltage quad switches ADG812 from
Analog Devices have been selected, mainly due to their small
area (5×4.5mm2), low RON resistance (0.5Ω) and low leak-
age currents (typically around few hundred pA). The LTC2055
zero-drift amplifier from Linear Technology has been selected
for integrators A and B of each channel. The input bias current
of this IC is typically around ±3pA.
The period of switching signals F1 and F2 has been
set at least ×10 smaller than the finite gain bandwidth of
the amplifier and sufficient settling time has been given. In
Fig. 2. The dual SC integrators-based bioinstrumentation platform, with its
four distinct compartments highlighted.
addition, the slew rate of the amplifier guaranteed its ability to
track the switches sufficiently. Finally, with the use of the 12-
bit, single-output DAC, AD5321, and an appropriate circuitry,
the bioinstrumentation board provides bipolar biasing voltages
to the sensor from -3.3V up to +3.3V with ∼1.6mV resolution,
using a standard three-electrode potentiostat architecture [5].
A summary of the PCB’s characteristics is shown in Table I.
TABLE I. BOARD’S CHARACTERISTICS
Board dimensions (mm) 110 x 110
DSP unit Altera MAX10 - 50MHz
Total current consumption (mA) ∼ 52
Power supply 5V (Battery or USB)
III. EXPERIMENTAL RESULTS
A. Board Characterisation
For the board’s initial characterisation, three separate exper-
iments have been conducted using a fully-controllable, high-
precision Keithley 6221 AC/DC current source. Initially, in
order to ensure that the responses of the fabricated circuit
comply with the mathematical description of the SC integrator,
a comparison between the actual circuit’s outputs and a SC
simulated model (LTSpice) similar to the one of Figure 1 has
been performed for the three ranges provided by the board.
DC current inputs were provided to the board with fixed
step at each range and the output voltage of each channel
was compared to the simulator. The results can be seen in
Figure 3. The lines labelled as unoptimised correspond to the
circuit’s voltage responses when integration time has been set
equal to the value used for the simulation. The lines labelled
as optimised refer to integration time slightly different than
the simulation one, in order to compensate for the circuit’s
nonidealities (e.g. capacitors have ±20% tolerances on their
nominal values). The optimised circuit responses deviate from
ideality no more than 15%, on average, demonstrating the
robustness of the system. Finally, the cumulative leakage
currents of switch ICs seem to affect only the lower limit of
Range 1 and they become negligible as input current increases.


































Fig. 3. Comparison between simulations, optimised and unoptimised exper-
imental results of the proposed architecture for three different current ranges.
In the second experiment, the linearity and resolution of the
system have been investigated. For this specific experiment,
Range 1 (see Table II) has been selected, since this configu-
ration provides the lowest possible current resolution. Current
ranges from 20nA up to 140nA, with step 10nA and from
30nA to 60nA with step 5nA have been selected. The results
are presented in Figure 4. Finally, we demonstrate the noise
properties of the system. For each of the three possible range
configurations, a sinusoidal current signal has been generated
with different amplitude and frequency. The properties of the
sinusoidal signals can be found in Table III. The results of the
Fast Fourier Transform (FFT) analysis are shown in Figure 5.
TABLE II. SUMMARY OF THE CHARACTERISATION EXPERIMENTS
Programmable Current Ranges
Current Range Resolution SC Integration Times
Range 1 5nA-420nA 5nA [U:130ms, O:125ms]
Range 2 420nA-25µA 100nA [U:2ms, O:1.8ms]
Range 3 25µA - 500µA 1µA [U:111µs, O:113µs]
Dynamic Current
Range 20 ∗ log10([500 ∗ 10
−6A]/[5 ∗ 10−9A]) = 100dB
U:unoptimised, O:optimised
B. Electrochemical Validation
Electrochemical detection was demonstrated using a
titrated series of NaCl solution samples analysed on a
three-electrode PCB-sensor. Electrodes comprise reference
(Ag|AgCl), working (Au) and counter (Au) and NaCl solution
samples were measured from 1M to 125mM in log2 dilu-
tions. An electrochemical cell was fabricated in PDMS and
sealed with PMMA. Fluidic ports through the PMMA top
layer allowed sample provision and exchange. Samples were
injected rapidly at first (500µL) to ensure complete sample
exchange and experimental measurements were taken under
flow (syringe pump, 140µL/min). The results can be found in
Figure 6.











































Fig. 4. Linearity and resolution characterisation of the fabricated board.


































Fig. 5. Noise analysis of each of the three range configurations of the system.
The signal’s frequency has been selected to be much lower compared to the
frequency of the clock signals F1 and F2.
TABLE III. PROPERTIES OF SINUSOIDAL TEST SIGNAL
Sinusoidal Current Properties
IDC Ip−p Frequency Sampling Frequency
Range 1 220nA 408nA 1Hz 1kHz
Range 2 13µA 25µA 10Hz 1kHz
Range 3 260µA 480µA 100Hz 1kHz
IV. CONCLUSION
This paper presents a paradigm shift for the bioinstru-
mentation platform of the “eELISA” detection approach. The
proposed circuitry relies upon the concept of dual SC integra-
tion in order to combine continuous current measurement with
accuracy and reconfigurability. The fabricated PCB has small
footprint and is battery-operated, making it fully-independent
from lab instruments or PC control. The obtained experimen-
tal results verify our initial hypothesis regarding the low-
noise, high-resolution properties of the instrument. Its mul-
tiple configuration combinations satisfy the electrochemical
requirements of the “eELISA” detection approach. We aspire










































Fig. 6. Electrochemical validation of the proposed board using NaCl
solutions. The system exhibits high degree of linearity with coefficient of
determination (R2) equal to 0.9551.
to progress our current work by exploiting the Low-Voltage
Differential Signalling inputs of FPGA platforms, in order to
perform A/D conversion on an FPGA and thus, provide a
complete embedded system for PCB-based biosensing.
ACKNOWLEDGMENT
The authors acknowledge the financial support of the En-
gineering and Physical Sciences Research Council (EPSRC),
EP/L020920/1 research grant.
REFERENCES
[1] M. Drancourt, A. Michel-Lepage, S. Boyer, and D. Raoult, “The Point-
of-Care Laboratory in Clinical Microbiology,” Clinical microbiology
reviews, vol. 29, no. 3, pp. 429–447, 2016.
[2] N. Vasilakis, K. I. Papadimitriou, D. Evans, H. Morgan, and T. Prodro-
makis, “The Lab-on-PCB Framework for Affordable, Electronic-Based
Point-of-Care Diagnostics: from Design to Manufacturing,” in IEEE-NIH
2016 Special Topics Conference on Healthcare Innovations and Point-
of-Care Technologies. IEEE, 2016.
[3] T. Prodromakis, Y. Liu, J. Yang, D. Hollinghurst, and C. Toumazou,
“A novel design approach for developing chemical sensing platforms
using inexpensive technologies,” in Biomedical Circuits and Systems
Conference (BioCAS), 2011 IEEE, Nov 2011, pp. 369–372.
[4] T. Prodromakis, Y. Liu, and C. Toumazou, “A low-cost disposable
chemical sensing platform based on discrete components,” Electron
Device Letters, IEEE, vol. 32, no. 3, pp. 417–419, 2011.
[5] K. I. Papadimitriou, D. Evans, H. Morgan, and T. Prodromakis, “A PCB-
based electronic ELISA system for rapid, portable infectious disease
diagnosis,” in Biomedical Circuits and Systems Conference (BioCAS),
2016 IEEE.
[6] K. I. Papadimitriou, I. Zeimpekis, D. Moschou, K. Sun, C. Hu, P. Ash-
burn, H. Morgan, and T. Prodromakis, “Towards a high-precision,
embedded system for versatile sensitive biosensing measurements,” in
Biomedical Circuits and Systems Conference (BioCAS), 2015 IEEE.
[7] K. I. Papadimitriou, C. Wang, M. L. Rogers, S. A. Gowers, C. L.
Leong, M. G. Boutelle, and E. M. Drakakis, “High-performance bioin-
strumentation for real-time neuroelectrochemical traumatic brain injury
monitoring,” Frontiers in Human Neuroscience, vol. 10, p. 212, 2016.
[8] M. M. Liu, Demystifying switched capacitor circuits. Newnes, 2006.
[9] B. Razavi, Design of analog CMOS integrated circuits. McGraw-Hill,
2001.
